Matsaloli

2022

Inshorar Likitan kasar Sin ta karɓi allurar mara allura.Ƙaddamar da haɗin gwiwa tare da Ma'aikatan Magunguna don nazarin allurar rigakafi.

2021

An ƙaddamar da QS-K a cikin Kasuwar Sinanci.

2019

An kammala karatun asibiti kuma aka buga akan Lancet, wannan shine gwaji na farko na asibiti da ke da alaƙa da NFIs a cikin duniya waɗanda ke cikin sama da masu ciwon sukari 400.

2018

An ƙaddamar da QS-P a cikin kasuwar Sinanci.QS-K an haɓaka kuma ya sami lambar yabo ta Reddot Design.

2017

An sami CE & ISO akan QS-M & QS-P, CFDA akan QS-P.

2015

QS-M ya sami lambar yabo ta Reddot Design da Red Star Design Award.

2014

An amince da QS Medical a matsayin Babban Kamfanin Fasaha na China, an haɓaka QS-P.

2012

QS-M ya sami amincewar CFDA.

2007

Canjin likita na QS zuwa Quinovare, an haɓaka QS-M.

2005

An kafa cibiyar binciken injector mara allura.